Is pulmonary hypertension protective against cardiac tamponade? A systematic review
Robert James Adrian,Stephen Alerhand,Andrew Liteplo,Hamid Shokoohi
DOI: https://doi.org/10.1007/s11739-024-03566-y
2024-04-17
Internal and Emergency Medicine
Abstract:The presence of pulmonary hypertension (PH) may affect whether cardiac tamponade physiology develops from a pericardial effusion. Specifically, the increased intracardiac pressure and right ventricular hypertrophy associated with PH would seemingly increase the intrapericardial pressure threshold at which the right-sided chambers collapse. In this systematic review, we examined the impact of PH on the incidence, in-hospital and long-term mortality, and echocardiographic findings of patients with cardiac tamponade. Using the PRISMA guideline, a systematic search was conducted in PubMed, Academic Search Premier, Web of Science, Google Scholar, and the Cochrane Database for studies investigating PH and cardiac tamponade. The Newcastle–Ottawa Scale was used to analyze the quality of returned studies. Primary outcomes included the incidence of cardiac tamponade, as well as in-hospital and long-term mortality rates. Secondary outcomes were the presence or absence of echocardiographic findings of cardiac tamponade in patients with PH. Forty-three studies (9 cohort studies and 34 case reports) with 1054 patients were included. The incidence of cardiac tamponade was significantly higher in patients with PH compared to those without PH, 2.0% (95% CI 1.2–3.2%) vs. 0.05% (95% CI 0.05–0.05%), p < 0.0001, OR 40.76 (95% CI 24.8–66.9). The incidence of tamponade in patients with a known pericardial effusion was similar in those with and without PH, 20.3% (95% CI 12.0–32.3%) and 20.9% (95% CI 18.0–24.1%), p = 0.9267, OR 0.97 (95% CI 0.50–1.87). In patients with tamponade, those with PH demonstrated a significantly higher in-hospital mortality than those without PH, 38.8% (95% CI 26.4–52.8%) vs. 14.4% (95% CI 14.2–14.6%), p < 0.0001, OR 3.77 (95% CI 2.12–6.70). Long-term mortality in patients with tamponade was significantly lower in those with PH than in those without PH, 45.5% (95% CI 33.0–58.5%) vs. 59.1% (95% CI 54.7–63.4%), p = 0.0258, OR 0.576 (95% CI 0.33–1.01). However, after stratifying by non-malignant etiologies, the long-term mortality benefit for those with PH disappeared. In the studies that described specific echocardiographic findings of cardiac tamponade, only 10.5% of patients with PH and tamponade showed right atrial and right ventricular collapse. When evaluating patients with pericardial effusions, physicians must recognize the effects of underlying PH on the incidence, in-hospital and long-term mortality rates, and potentially atypical echocardiographic presentation of cardiac tamponade.
medicine, general & internal